Additional studies have found that inhibition of SMO in human OSA cell lines and mouse xenografts can inhibit canonical Hh signaling and may be an effective therapeutic approach for the treatment of human OSA [6]. Here, SMO is linked to obstructive sleep apnea syndrome.